PuSH - Publikationsserver des Helmholtz Zentrums München

Hippich, M. ; Beyerlein, A. ; Hagopian, W.A.* ; Krischer, J.P.* ; Vehik, K.* ; Knoop, J. ; Winker, C. ; Toppari, J.* ; Lernmark, Å.* ; Rewers, M.J.* ; Steck, A.K.* ; She, J.X.* ; Akolkar, B.* ; Robertson, C.C.* ; Onengut-Gumuscu, S.* ; Rich, S.S.* ; Bonifacio, E.* ; Ziegler, A.-G. ; The Teddy Study Group*

Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families.

Diabetes 68, 847-857 (2019)
Verlagsversion Postprint Forschungsdaten DOI PMC
Open Access Green
The risk for autoimmunity and subsequently type 1 diabetes is 10-fold higher in children with a first-degree family history of type 1 diabetes (FDR children) than in children in the general population (GP children). We analyzed children with high-risk HLA genotypes (n = 4,573) in the longitudinal TEDDY birth cohort to determine how much of the divergent risk is attributable to genetic enrichment in affected families. Enrichment for susceptible genotypes of multiple type 1 diabetes-associated genes and a novel risk gene, BTNL2, was identified in FDR children compared with GP children. After correction for genetic enrichment, the risks in the FDR and GP children converged but were not identical for multiple islet autoantibodies (hazard ratio [HR] 2.26 [95% CI 1.6-3.02]) and for diabetes (HR 2.92 [95% CI 2.05-4.16]). Convergence varied depending upon the degree of genetic susceptibility. Risks were similar in the highest genetic susceptibility group for multiple islet autoantibodies (14.3% vs .12.7%) and diabetes (4.8% vs. 4.1%) and were up to 5.8-fold divergent for children in the lowest genetic susceptibility group, decreasing incrementally in GP children but not in FDR children. These findings suggest that additional factors enriched within affected families preferentially increase the risk of autoimmunity and type 1 diabetes in lower genetic susceptibility strata.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.199
1.796
13
15
Tags
icb_biostatistics
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Islet Autoantibodies; Susceptibility; Sarcoidosis; Expression; Haplotypes; Prediction
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Zeitschrift Diabetes
Quellenangaben Band: 68, Heft: 3, Seiten: 847-857 Artikelnummer: , Supplement: ,
Verlag American Diabetes Association
Verlagsort Alexandria, VA.
Begutachtungsstatus Peer reviewed
POF Topic(s) 30201 - Metabolic Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Helmholtz Diabetes Center
Enabling and Novel Technologies
PSP-Element(e) G-502100-001
G-503800-001
Scopus ID 85063639692
PubMed ID 30655385
Erfassungsdatum 2019-03-07